Evidence map›Paper›PMID 42459594›Full record

ArticleRespirology case reports2026

Coexistence of Multiple Endocrine Neoplasia Type 2B and Centri-Acinar Emphysema With Alpha-1 Antitrypsin Deficiency: A Case Report.

Mohammad Javad Mohammadifard, Abolfazl Taghinejad, FatemehAlsadat AghaeiMeybodi

Abstract read
In one paragraph

Article in Respirology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mohammad Javad MohammadifardDepartment of Internal Medicine, Faculty of Medicine Shahid Sadoughi University of Medical Sciences and Health Services Yazd Iran.
Abolfazl TaghinejadDepartment of Internal Medicine, Faculty of Medicine Shahid Sadoughi University of Medical Sciences and Health Services Yazd Iran.ORCID https://orcid.org/0009-0009-4931-0820
FatemehAlsadat AghaeiMeybodiDepartment of Internal Medicine, Faculty of Medicine Shahid Sadoughi University of Medical Sciences and Health Services Yazd Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alpha-1 antitrypsin deficiency (AATD) is a hereditary disorder that reduces a key lung-protective protein, predisposing individuals to early-onset emphysema. Multiple Endocrine Neoplasia type 2B (MEN2B), caused by RET gene mutations, is a rare syndrome characterised by aggressive medullary thyroid carcinoma and pheochromocytoma. Coexistence of MEN2B and AATD has not previously been reported. A 32-year-old woman with a history of medullary thyroid carcinoma and prior total thyroidectomy presented with severe dyspnea, generalised edema and weakness after discontinuing levothyroxine. She was tachycardic and hypoxemic, with wheezing and bilateral crackles. Laboratory evaluation showed leukocytosis, thrombocytosis, electrolyte abnormalities and markedly reduced alpha-1 antitrypsin levels. Chest CT revealed bilateral cystic and emphysematous changes, and spirometry confirmed severe obstructive disease. Supportive therapy and symptom-directed management improved her respiratory status. The diagnoses of MEN2B and AATD were made based on clinical features, biochemical findings and imaging results, as confirmatory genetic testing was not available according to sanction. This case highlights the extremely rare coexistence of MEN2B and AATD. Overlapping manifestations contributed to delayed recognition. Clinicians should consider rare genetic conditions when common diagnoses do not fully explain a patient's presentation.

Indexed as

alpha‐1 antitrypsin deficiencyemphysemamedullary thyroid carcinomaMEN2b

Identifiers

PMID42459594
PMCPMC13368433

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.